Acorda Therapeutics reported $38.5M in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US USD 161.58M 6.63M
Acorda Therapeutics ACOR:US USD 38.5M 6.47M
Agios Pharmaceuticals AGIO:US USD 90.16M 10.35M
ALKERMES ALKS:US USD 313M 2.32M
Amgen AMGN:US USD 3.91B 504M
Anika Therapeutics ANIK:US USD 28.58M 14.46M
Aptinyx Inc APTX:US USD 14.66M 2.45M
Arrowhead Research ARWR:US USD 115.4M 10.08M
Biogen BIIB:US USD 1.19B 1.45B
Biomarin Pharmaceutical BMRN:US USD 507.76M 13.12M
Cara Therapeutics CARA:US USD 34.66M 7.18M
Clovis Oncology CLVS:US USD 74.9M 16.63M
Cytokinetics CYTK:US USD 133.2M 33.36M
Enanta Pharmaceuticals ENTA:US USD 47.36M 4.65M
Gilead Sciences GILD:US USD 4.2B 26M
GlaxoSmithKline GSK:LN GBP 6.64B 790M
Halozyme Therapeutics HALO:US USD 128.4M 10.09M
Heron Therapeutics HRTX:US USD 68.44M 8.69M
Insmed INSM:US USD 195.43M 41.89M
Ligand Pharmaceuticals LGND:US USD 65.45M 9.36M
Mannkind MNKD:US USD 42.43M 3.09M
Merck MRK:GR EUR 4.57B 181M
Moderna Inc MRNA:US USD 2.2B 104M
Neurocrine Biosciences NBIX:US USD 300.1M 93.4M
Novartis NOVN:VX USD 10.67B 183M
Pfizer PFE:US USD 13.23B 2.41B
Teva Pharmaceutical TEVA:IT USD 3.18B 1.56B
Ultragenyx Pharmaceutical RARE:US USD 315.77M 84.83M
Vertex Pharmaceuticals VRTX:US USD 1.21B 117.7M